一些人看不上的INDIA

贵圈

政府都对党
注册
2014-10-21
消息
32,821
荣誉分数
6,152
声望点数
373

India's dramatic fall in virus cases leaves experts stumped​

Krutika Pathi and Aniruddha Ghosal
The Associated PressStaff
Contact
Published Tuesday, February 16, 2021 2:15AM EST




CTV National News: India's pandemic success

NEW DELHI -- When the coronavirus pandemic took hold in India, there were fears it would sink the fragile health system of the world's second-most populous country. Infections climbed dramatically for months and at one point India looked like it might overtake the United States as the country with the highest case toll.
But infections began to plummet in September, and now the country is reporting about 11,000 new cases a day, compared to a peak of nearly 100,000, leaving experts perplexed.
They have suggested many possible explanations for the sudden drop -- seen in almost every region -- including that some areas of the country may have reached herd immunity or that Indians may have some preexisting protection from the virus.

可笑家们也不得不承认印度了。当然了不敢提HCQ。不敢提印度高感染率的背景下的很低的稳定的重症率。
 
新德里数字到底是不是糊弄事儿呢?

NEW DELHI (Reuters) - India announced an expansion of its COVID-19 vaccination programme on Wednesday but warned that breaches of coronavirus protocols could worsen an infection surge in many states.




A healthcare worker uses an oximeter to check oxygen level of passengers at a railway station, amidst the spread of the coronavirus disease (COVID-19), in Mumbai, India, February 22, 2021. REUTERS/Niharika Kulkarni
Nearly a month after the health minister declared that COVID-19 had been contained, states such as Maharashtra in the west and Kerala in the south have reported a spike in cases amid growing reluctance to wear masks and maintain social distancing.

India’s infections are the second highest in the world at 11.03 million, swelled by a further 13,742 in the past 24 hours, health ministry data showed. Deaths rose by a two-week high of 104 to 156,567.

“Any laxity in implementing stringent measures to curb the spread, especially in view of new strains of virus..., could compound the situation,” the ministry said in a statement singling out nine states and a federal territory.

India has confirmed the long-time presence of two mutant variants - N440K and E484Q - in addition to those first detected in Brazil, Britain and South Africa.


TESTS FALLING​

The health ministry said that while cases in the states of Chhattisgarh, Gujarat, Kerala, Maharashtra, Madhya Pradesh and Punjab, as well as the federal territory of Jammu and Kashmir, were rising, the proportion of high-accuracy RT-PCR tests in those places was falling because many states prefer antigen tests, which are cheaper and quicker but less accurate.

The federal government is worried excessive reliance on rapid antigen tests could undercount cases, leading to real infections going unchecked and spreading the disease.

Cases have also risen in Karnataka, Tamil Nadu and West Bengal.

In the past week, a third of India’s 36 states and union territories have reported an average of more than 100 new cases each day, with Kerala and Maharashtra both registering more than 4,000, in a trend experts link to the reopening of schools and suburban train services.

Maharashtra reported 8,807 new COVID-19 cases on Wednesday, the highest in nearly five months. Of those, 1,167 were in Mumbai, India’s financial capital.


The government has also asked states to speed up vaccinations for healthcare and frontline workers. Just about 11 million people have received one or two doses in a campaign that began on Jan. 16. The target is 300 million by August.

From March 1, India will start vaccinating people above 60 and those older than 45 with health conditions free of charge in about 10,000 government hospitals and for a fee in more than 20,000 private facilities, the government said.

Earlier on Wednesday, a regulatory panel sought more data from drugmaker Dr. Reddy’s Laboratories for emergency authorisation of Russia’s Sputnik V COVID-19 vaccine, a senior official with direct knowledge of the discussions said.

The Central Drugs Standard Control Organisation did not immediately reply to a Reuters request for confirmation.
 
在已经有众多随机临床试验的情况下,求你不要再扯什么 HCQ 了。印度自己都没说新增病例减少和 HCQ 有什么关系。

India's dramatic fall in virus cases leaves experts stumped​

Krutika Pathi and Aniruddha Ghosal
The Associated PressStaff
Contact
Published Tuesday, February 16, 2021 2:15AM EST




CTV National News: India's pandemic success
NEW DELHI -- When the coronavirus pandemic took hold in India, there were fears it would sink the fragile health system of the world's second-most populous country. Infections climbed dramatically for months and at one point India looked like it might overtake the United States as the country with the highest case toll.
But infections began to plummet in September, and now the country is reporting about 11,000 new cases a day, compared to a peak of nearly 100,000, leaving experts perplexed.
They have suggested many possible explanations for the sudden drop -- seen in almost every region -- including that some areas of the country may have reached herd immunity or that Indians may have some preexisting protection from the virus.

可笑家们也不得不承认印度了。当然了不敢提HCQ。不敢提印度高感染率的背景下的很低的稳定的重症率。
 
很可能是大量无症状感染,形成了群体免疫。
 
1614259168909.png
 

Despite global scepticism, India distributed over 100 million HCQ tablets for Covid-19​


在已经有众多随机临床试验的情况下,求你不要再扯什么 HCQ 了。印度自己都没说新增病例减少和 HCQ 有什么关系。

不去看真实新闻。直接相信。这叫信仰。信仰的人有福,但是没有逻辑。
 
这个新闻有个球用。你自己算算,111.6 million pills of hydroxychloroquine,不够 1/13 印度人分上一片的。
按照你说的 prevention 的原则,至少是要每日服用。这个新闻正是说明了印度新增病例减少和 HCQ 无关。

Despite global scepticism, India distributed over 100 million HCQ tablets for Covid-19​




不去看真实新闻。直接相信。这叫信仰。信仰的人有福,但是没有逻辑。
 
哈哈,可笑家,只要讲逻辑,不对funding和政治屈服。可以是科学家!
 
这个新闻有个球用。你自己算算,111.6 million pills of hydroxychloroquine,不够 1/13 印度人分上一片的。
按照你说的 prevention 的原则,至少是要每日服用。这个新闻正是说明了一个问题,印度新增病例减少和 HCQ 无关。
这叫distributed。政府派发,你以为印度人的HCQ全部来自政府派发? 以色列不派发,医生随便开,结果也出现了类似印度的吻合曲线。。。
 
这个新闻有个球用。你自己算算,111.6 million pills of hydroxychloroquine,不够 1/13 印度人分上一片的。
按照你说的 prevention 的原则,至少是要每日服用。这个新闻正是说明了印度新增病例减少和 HCQ 无关。
我从来没说HCQ可以当疫苗用。还prevention,可笑家
 
和每人每日服用,相去甚远。我相信 treatment 和 prevention 两种随机临床试验累积的结果,显示没有用,
因此 FDA 在 6月 取消了 HCQ 对新冠的适应症临时授权。
这叫distributed。政府派发,你以为印度人的HCQ全部来自政府派发?
 
最后编辑:
逻辑啊,高感染率,低死亡率。

稍微有点逻辑的,就知道,这不是预防,prevention。 你真全没逻辑。
 
后退
顶部